Dja Global Pharmaceuticals
Pharmaceuticals, 325 Sentry Pkwy, Blue Bell, Pennsylvania, 19422, United States, 1-10 Employees
Who is DJA GLOBAL PHARMACEUTICALS
The goal of DJA is to bridge the complex areas of discovery, pharmaceutical development and global regulatory science. DJA offers: 1. 100+ years collective experience in driving global re...
Read More
-
Headquarters: 325 Sentry Pkwy, Blue Bell, Pennsylvania, 19422, United States
-
Date Founded: 2001
-
Employees: 1-10
-
Revenue: $5 Million to $10 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 8742
Does something look wrong? Fix it. | View contact records from DJA GLOBAL PHARMACEUTICALS
DJA Global Pharmaceuticals Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding DJA Global Pharmaceuticals
Answer: DJA Global Pharmaceuticals's headquarters are located at 325 Sentry Pkwy, Blue Bell, Pennsylvania, 19422, United States
Answer: DJA Global Pharmaceuticals's official website is https://djaglobalpharma.com
Answer: DJA Global Pharmaceuticals's revenue is $5 Million to $10 Million
Answer: DJA Global Pharmaceuticals's SIC: 8742
Answer: DJA Global Pharmaceuticals has 1-10 employees
Answer: DJA Global Pharmaceuticals is in Pharmaceuticals
Answer: DJA Global Pharmaceuticals contact info: Phone number: Website: https://djaglobalpharma.com
Answer: The goal of DJA is to bridge the complex areas of discovery, pharmaceutical development and global regulatory science. DJA offers: 1. 100+ years collective experience in driving global regulatory approvals for drugs, biologics, combination products and devices. 2. Strategic and operational direction for product lifecycle management in all therapeutic areas. 3. Strategic due-diligence to achieve business objectives. 4. Results-oriented integrated product development involving CROs, CMOs and other external partners. 5. Resolving complex supply chain challenges and averting product recalls. 6. Developing and implementing GxP systems and managing successful agency inspections. 7. eCTD submission & publishing support services Since 2002, DJA has built long-term relationships with 25+ clients who have benefited from: - 8+ NDA/MAA/NDS approvals [including reversal of a non-approval action] in 5 therapeutic areas - 355+ agency submissions [IND/CTA/IDE] in over 30 countries - 40+ DMF/CEP submissions [human/veterinary products] in 28+ countries - 35 successful pre-approval inspections - led 45+ successful FDA/Canadian/EMEA meetings for 30+ products in all phases of development and 8 therapeutic areas
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Powered by
Sign in to CIENCE GO Data to uncover contact details
Free credits every month